IDH1 and glioblastoma: The 2016 World Health Organization Classification of Tumors of the Central Nervous System (CNS WHO) presents a major restructuring of the diffuse gliomas and incorporates new entities defined using both histological and molecular features, including glioblastoma, isocitrate dehydrogenase (IDH)-mutant status, and 1p/19q codeletion [2].